News in Numbers

According to GlobalData analysis, the anaplastic lymphoma kinase tests (ALK) test market was valued at $22.1m in 2023 and is projected to reach $27.5m by 2033.

A major landmark study published by The Lancet reveals that global immunisation efforts have saved an estimated 154 million lives – or the equivalent of 6 lives every minute of every year – over the past 50 years.

GlobalData estimates that 625,000 new brain tumour cases are diagnosed annually worldwide, with 70,000 of those cases in the US. May is designated as Brain Tumor Awareness Month to enhance public understanding of the challenges associated with brain tumour diagnosis and treatment and highlight ongoing research efforts.

Novo Holdings is planning a $200.3m investment to support startups focused on disruptive technologies, including quantum computing, sensing, and algorithms, for applications in healthcare.

Up to 4,000 people with sickle cell disease in England could benefit from the drug Voxelotor if recommended by their clinician, which will offer an additional treatment option following its approval by the National Institute for Health and Care Excellence (NICE).